Literature DB >> 23483200

Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.

Joyonna C Gamble-George1, Jordan R Conger, Nolan D Hartley, Prerna Gupta, Joshua J Sumislawski, Sachin Patel.   

Abstract

RATIONALE: Central CB1 cannabinoid receptors regulate anxiety-like and appetitive consummatory behaviors. Pharmacological antagonism/inverse-agonism of CB1 receptors increases anxiety and decreases appetitive behaviors; however, neither well-defined dose nor context dependence of these effects has been simultaneously assessed in one behavioral assay.
OBJECTIVES: We sought to determine the context and dose dependence of the effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in a model that allowed for simultaneous detection of anxiety-like and consummatory-related behaviors.
METHODS: We determined the effects of the CB1 receptor antagonist/inverse-agonist, rimonabant, in the novelty-induced hypophagia (NIH) assay in juvenile male ICR mice.
RESULTS: Rimonabant dose-dependently decreased consumption of a palatable reward solution completely independent of contextual novelty. Grooming and scratching behavior was also increased by rimonabant in a context-independent manner. In contrast, rimonabant increased feeding latency, a measure of anxiety-like behaviors, only in a novel, mildly anxiogenic context. The effects of rimonabant were specific since no effects of rimonabant on despair-like behavior were observed in the tail suspension assay. Blockade of CB2 receptors had no effect on novelty-induced increases in feeding latency or palatable food consumption.
CONCLUSIONS: Our findings indicate that CB1 receptor blockade decreases the hedonic value of palatable food irrespective of environmental novelty, whereas the anxiogenic-like effects are highly context-dependent. Blockade of CB2 receptors does not regulate either anxiety-like or consummatory behaviors in the NIH assay. These findings suggest that rimonabant modulates distinct and dissociable neural processes regulating anxiety and consummatory behavior to sculpt complex and context-dependent behavioral repertories.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23483200      PMCID: PMC3707973          DOI: 10.1007/s00213-013-3042-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  66 in total

1.  Modulation of anxiety through blockade of anandamide hydrolysis.

Authors:  Satish Kathuria; Silvana Gaetani; Darren Fegley; Fernando Valiño; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Giovanna La Rana; Antonio Calignano; Arcangela Giustino; Maria Tattoli; Maura Palmery; Vincenzo Cuomo; Daniele Piomelli
Journal:  Nat Med       Date:  2002-12-02       Impact factor: 53.440

Review 2.  Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.

Authors:  Stephanie C Dulawa; Rene Hen
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

Review 3.  Endocannabinoids and drug dependence.

Authors:  Daniela Parolaro; Daniela Viganò; Tiziana Rubino
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-12

Review 4.  Involvement of the endocannabinoid system in drug addiction.

Authors:  Rafael Maldonado; Olga Valverde; Fernando Berrendero
Journal:  Trends Neurosci       Date:  2006-02-17       Impact factor: 13.837

Review 5.  Cannabinoids, opioids and eating behavior: the molecular face of hedonism?

Authors:  Daniela Cota; Matthias H Tschöp; Tamas L Horvath; Allen S Levine
Journal:  Brain Res Rev       Date:  2005-12-20

Review 6.  The endocannabinoid system and the treatment of obesity.

Authors:  Uberto Pagotto; Valentina Vicennati; Renato Pasquali
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

7.  CB1 cannabinoid receptor-mediated modulation of food intake in mice.

Authors:  Jenny L Wiley; James J Burston; Darnica C Leggett; Olga O Alekseeva; Raj K Razdan; Anu Mahadevan; Billy R Martin
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

8.  Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.

Authors:  Sachin Patel; Cecilia J Hillard
Journal:  J Pharmacol Exp Ther       Date:  2006-03-28       Impact factor: 4.030

Review 9.  Endocannabinoids in appetite control and the treatment of obesity.

Authors:  T C Kirkham; S A Tucci
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-06       Impact factor: 4.388

10.  Cannabis use in HIV for pain and other medical symptoms.

Authors:  Emily Woolridge; Simon Barton; Jonathon Samuel; Jess Osorio; Andrew Dougherty; Anita Holdcroft
Journal:  J Pain Symptom Manage       Date:  2005-04       Impact factor: 3.612

View more
  20 in total

1.  Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence.

Authors:  Samuel W Centanni; Bridget D Morris; Joseph R Luchsinger; Gaurav Bedse; Tracy L Fetterly; Sachin Patel; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2018-11-02       Impact factor: 7.853

2.  The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System.

Authors:  Anthony L Berger; Angela M Henricks; Janelle M Lugo; Hayden R Wright; Collin R Warrick; Martin A Sticht; Maria Morena; Itziar Bonilla; Sarah A Laredo; Rebecca M Craft; Loren H Parsons; Pedro R Grandes; Cecilia J Hillard; Matthew N Hill; Ryan J McLaughlin
Journal:  Biol Psychiatry       Date:  2018-05-08       Impact factor: 13.382

Review 3.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

4.  Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol Drinking.

Authors:  Katherine M Holleran; Hadley H Wilson; Tracy L Fetterly; Rebecca J Bluett; Samuel W Centanni; Rachel A Gilfarb; Lauren E R Rocco; Sachin Patel; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2016-01-11       Impact factor: 7.853

5.  Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.

Authors:  Jill R Turner; Derek S Wilkinson; Rachel Lf Poole; Thomas J Gould; Gregory C Carlson; Julie A Blendy
Journal:  Neuropsychopharmacology       Date:  2013-04-29       Impact factor: 7.853

Review 6.  Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.

Authors:  Matthew N Hill; Patrizia Campolongo; Rachel Yehuda; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2017-07-26       Impact factor: 7.853

7.  Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine densities in brain regions important to zebra finch vocal learning and production in an antidepressant-sensitive manner.

Authors:  Tessa L Holland; Ken Soderstrom
Journal:  Brain Res       Date:  2017-07-22       Impact factor: 3.252

8.  Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation.

Authors:  Brian C Shonesy; Rebecca J Bluett; Teniel S Ramikie; Rita Báldi; Daniel J Hermanson; Philip J Kingsley; Lawrence J Marnett; Danny G Winder; Roger J Colbran; Sachin Patel
Journal:  Cell Rep       Date:  2014-11-26       Impact factor: 9.423

9.  Endocannabinoid signaling as an intrinsic component of the circuits mediating adaptive responses to repeated stress exposure in adult male sprague dawley rats.

Authors:  Ryan J Newsom; Jacob Stafford; Robert J Garcia; Serge Campeau
Journal:  Stress       Date:  2019-09-11       Impact factor: 3.493

10.  Delineation of an insula-BNST circuit engaged by struggling behavior that regulates avoidance in mice.

Authors:  Joseph R Luchsinger; Tracy L Fetterly; Kellie M Williford; Gregory J Salimando; Marie A Doyle; Jose Maldonado; Richard B Simerly; Danny G Winder; Samuel W Centanni
Journal:  Nat Commun       Date:  2021-06-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.